Long-term surgical outcomes of combined Ahmed glaucoma valve implantation and phacoemulsification with intraocular lens implantation for patients with glaucoma secondary to iridocorneal endothelial syndrome.
Humans
Phacoemulsification
/ methods
Female
Male
Retrospective Studies
Glaucoma Drainage Implants
Lens Implantation, Intraocular
/ methods
Middle Aged
Intraocular Pressure
/ physiology
Visual Acuity
/ physiology
Aged
Glaucoma
/ surgery
Iridocorneal Endothelial Syndrome
/ surgery
Follow-Up Studies
Treatment Outcome
Adult
Ahmed glaucoma valve
Glaucoma secondary to ICE syndrome
Phacoemulsification and intraocular lens implantation
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
20
07
2024
accepted:
21
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
To assess the long-term outcomes of patients with glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE) who underwent Ahmed glaucoma valve (AGV) implantation combined with phacoemulsification and intraocular lens (IOL) implantation surgery. In this non-comparative retrospective case series study, twelve patients with uncontrolled GS-ICE and cataract underwent Ahmed aqueous shunt combined with phacoemulsification and IOL implantation surgery at Beijing Tongren Eye Center between June 2014 and June 2022. Main medical records included best-corrected visual acuity (BCVA), intraocular pressure (IOP), number of antiglaucoma medications (AGM), corneal status and further surgical interventions. Surgical success was defined as a postoperative IOP ≥ 6mmHg and ≤ 21mmHg without (complete success) or with/without (qualified success) topical AGM and vision of at least light perception during the follow-up period. Twelve eyes of twelve patients were reviewed. Preoperative IOP was decreased from a mean of 38.5 ± 6.7 mmHg on 3.3 ± 0.9 AGM to a mean of 16.3 ± 4.3 mmHg (P<0.001) on 0.6 ± 1.1 medications (P<0.001) at the last follow-up (47.0 ± 24.7 months). Eight eyes (66.7%) had stable vision or at least one line improvement than that before surgery. Eight eyes (66.7%) achieved qualified success and six eyes (50.0%) achieved complete success after surgery. The surgical procedure had a qualified survival of 91.7% at 1 year, 82.5% at 3 years, 72.2% at 5 years, and 48.1% at 7 years. AGV implantation combined with phacoemulsification and IOL implantation seems to be an effective method in IOP control and vision maintain for patients with GS-ICE. The combined surgical procedure may be a reliable option for those GS-ICE patients with coexisting cataract.
Sections du résumé
BACKGROUND
BACKGROUND
To assess the long-term outcomes of patients with glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE) who underwent Ahmed glaucoma valve (AGV) implantation combined with phacoemulsification and intraocular lens (IOL) implantation surgery.
METHODS
METHODS
In this non-comparative retrospective case series study, twelve patients with uncontrolled GS-ICE and cataract underwent Ahmed aqueous shunt combined with phacoemulsification and IOL implantation surgery at Beijing Tongren Eye Center between June 2014 and June 2022. Main medical records included best-corrected visual acuity (BCVA), intraocular pressure (IOP), number of antiglaucoma medications (AGM), corneal status and further surgical interventions. Surgical success was defined as a postoperative IOP ≥ 6mmHg and ≤ 21mmHg without (complete success) or with/without (qualified success) topical AGM and vision of at least light perception during the follow-up period.
RESULTS
RESULTS
Twelve eyes of twelve patients were reviewed. Preoperative IOP was decreased from a mean of 38.5 ± 6.7 mmHg on 3.3 ± 0.9 AGM to a mean of 16.3 ± 4.3 mmHg (P<0.001) on 0.6 ± 1.1 medications (P<0.001) at the last follow-up (47.0 ± 24.7 months). Eight eyes (66.7%) had stable vision or at least one line improvement than that before surgery. Eight eyes (66.7%) achieved qualified success and six eyes (50.0%) achieved complete success after surgery. The surgical procedure had a qualified survival of 91.7% at 1 year, 82.5% at 3 years, 72.2% at 5 years, and 48.1% at 7 years.
CONCLUSION
CONCLUSIONS
AGV implantation combined with phacoemulsification and IOL implantation seems to be an effective method in IOP control and vision maintain for patients with GS-ICE. The combined surgical procedure may be a reliable option for those GS-ICE patients with coexisting cataract.
Identifiants
pubmed: 39482590
doi: 10.1186/s12886-024-03740-y
pii: 10.1186/s12886-024-03740-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
476Subventions
Organisme : Beijing Hospitals Youth Talent Program
ID : 2021-YJJ-ZZL-036
Informations de copyright
© 2024. The Author(s).
Références
Silva Luis,Najafi Ahmad,Suwan Yanin, et al, et al. Iridocorneal Endothelial Syndrome [J] Surv Ophthalmol. 2018;63:665–76.
Kidd M, Hetherington J, Magee S. Surgical results in iridocorneal endothelial syndrome. Arch Ophthalmol. 1988;106:199–201.
doi: 10.1001/archopht.1988.01060130209027
pubmed: 3341974
Walkden A, Au L. Iridocorneal endothelial syndrome: clinical perspectives. Clin Ophthalmol. 2018;12:657–64.
doi: 10.2147/OPTH.S143132
pubmed: 29670326
Chandran P, Rao HL, Mandal AK, et al. Outcomes of primary trabeculectomy with mitomycin-c in glaucoma secondary to iridocorneal endothelial syndrome. J Glaucoma. 2016;25:e652–6.
doi: 10.1097/IJG.0000000000000268
pubmed: 25943731
Mao Zhen,Guo Xinxing,Zhong Yimin. Surgical outcomes of Ahmed glaucoma valve implantation in patients with glaucoma secondary to iridocorneal endothelial syndrome [J]. Eye (Lond). 2021;35:608–15.
doi: 10.1038/s41433-020-0912-2
Gebremichael Bayu G et al. Mohamed Ashik,Chaurasia Sunita,. Outcomes of Ahmed Glaucoma Drainage Implant in Eyes With Glaucoma Secondary to Iridocorneal Endothelial Syndrome [J]. J Glaucoma, 2020, 29: 567–571.
Kim DK, Aslanides IM, Schmidt CM, et al. Long-term outcome of aqueous shunt surgery in ten patients with iridocorneal endothelial syndrome. Ophthalmology. 1999;106:1030–4.
doi: 10.1016/S0161-6420(99)00529-1
pubmed: 10328409
Chan Poemen P, Li Emmy Y, Tsoi Kelvin KF, et al. Cost-effectiveness of Phacoemulsification Versus Combined Phacotrabeculectomy for Treating Primary. Angle Clos Glaucoma [J] J Glaucoma. 2017;26:911–22.
Parish R, Minckler D. Late blebitis, the filtering surgery time bomb (editorial). Ophthalmology. 1996;103:1167–8.
doi: 10.1016/S0161-6420(96)30527-7
Feng B, Tang X, Chen H, et al. Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients. Int Ophthalmol. 2018;38(5):2117–26.
doi: 10.1007/s10792-017-0712-2
pubmed: 28993974
Laganowski HC, Kerr Muir MG, Hitchings RA. Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992;110:346–50.
doi: 10.1001/archopht.1992.01080150044025
pubmed: 1543451
Yan Chenxi,Yu Yibo,Wang Wei. et al. Long-term effects of mild cataract extraction versus laser peripheral iridotomy on anterior chamber morphology in primary angle-closure suspect eyes [J]. Br J Ophthalmol et al. 2023, undefined: undefined.
Nonaka A, Kondo T, Kikuchi M, et al. Angle widening and alteration of ciliary process configuration after cataract surgery for primary angle closure. Ophthalmology. 2006;113:437–41.
doi: 10.1016/j.ophtha.2005.11.018
pubmed: 16513457
Nonaka A, Kondo T, Kikuchi M, et al. Cataract surgery for residual angle closure after peripheral laser iridotomy. Ophthalmology. 2005;112:974–9.
doi: 10.1016/j.ophtha.2004.12.042
pubmed: 15885784
Man X, Chan NCY, Baig N, et al. Anatomical effects of clear lens extraction by phacoemulsification versus trabeculectomy on anterior chamber drainage angle in primary angle-closure glaucoma (PACG) patients. Graefes Arch Clin Exp Ophthalmol. 2015;253:773–8.
doi: 10.1007/s00417-015-2936-z
pubmed: 25644619
Hayashi K, Hayashi H, Nakao F, et al. Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma. Ophthalmology. 2000;107:698–703.
doi: 10.1016/S0161-6420(00)00007-5
pubmed: 10768331
Chung AN, Aung T, Wang JC, Chew PT. Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma with cataract. Am J Ophthalmol. 2004;137(2):294–300.
doi: 10.1016/j.ajo.2003.08.036
pubmed: 14962420
Doe EA, Budenz DL, Gedde SJ, Imami NR. Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome. Ophthalmology. 2001;108(10):1789–95.
doi: 10.1016/S0161-6420(01)00725-4
pubmed: 11581050
Zhang Q, Liu Y, Thanapaisal S, et al. The Effect of Tube Location on corneal endothelial cells in patients with Ahmed Glaucoma Valve. Ophthalmology. 2021;128(2):218–26.
doi: 10.1016/j.ophtha.2020.06.050
pubmed: 32603727
Senthilkumar Rajendrababu Sharmila A, Tara Techi, Dodum, et al. Short-term outcomes of micropulse transscleral cyclophotocoagulation as a primary versus additional therapy in eyes with uncontrolled glaucoma [J]. Indian J Ophthalmol. 2023;71:140–5.
doi: 10.4103/ijo.IJO_1289_22
pubmed: 36588224
Deng YZS,Ye, Wenqing et al. Achieving Inner Aqueous Drain in Glaucoma Secondary to Iridocorneal Endothelial Syndrome: One Year Results of Penetrating Canaloplasty[J]. Am J Ophthalmol, 2022, 243: 83–90.